Role of endothelium and nitric oxide in histamine-induced responses in human cranial arteries and detection of mRNA encoding H1- and H2-receptors by RT-PCR
- PMID: 9146885
- PMCID: PMC1564650
- DOI: 10.1038/sj.bjp.0701097
Role of endothelium and nitric oxide in histamine-induced responses in human cranial arteries and detection of mRNA encoding H1- and H2-receptors by RT-PCR
Abstract
1. Histamine induces relaxation of human cranial arteries. Studies have revealed that the relaxant histamine H1-receptor predominates in human cerebral and the H2-receptor in temporal arteries, while H1- and H2-receptors are of equal importance in the middle meningeal artery. The purpose of the present study was to examine the role of the endothelium and nitric oxide in histamine-induced responses and to show the presence of mRNA encoding H1- and H2-receptors in human cranial arteries. 2. Electrophoresis of polymerase chain reaction (PCR) products from human cerebral, middle meningeal and temporal arteries, demonstrated products corresponding to mRNA encoding both H1- and H2-receptors in arteries with and without endothelium. The amplified PCR products were sequenced and showed 100% homology with the published sequences of these histamine receptors. 3. A sensitive in vitro system was used to study vasomotor responses to histamine. In precontracted cerebral, middle meningeal and temporal arteries with and without endothelium, histamine caused a concentration-dependent relaxation with Imax values between 87% and 81% and pIC50 values between 8.14 and 7.15. In arteries without endothelium the histamine-induced relaxation was significantly less potent (Imax values between 87% and 66% and pIC50 values between 7.01 and 6.67) than in cranial arteries with an intact endothelium. 4. This addition of histamine to arteries without endothelium and pretreated with the histamine H2-antagonist, cimetidine (10(-5) M), caused a concentration-dependent contraction of the cranial arteries with Emax values between 86% and 29% and pEC50 values between 7.53 and 6.77. This contraction was blocked by the histamine H1-receptor antagonist, mepyramine (10(-7) M), and even turned into a relaxation with Imax values between 84% and 14% and pIC50 values between 7.42 and 5.86. 5. The nitric oxide synthase inhibitor NG-nitro-L-arginine methyl ester (L-NAME, 3 x 10(-5) M) significantly inhibited the relaxant response to histamine in cerebral and temporal arteries (pIC50 values between 7.43 and 7.13). The combined treatment with L-NAME (3 x 10(-5) M) and cimetidine (10(-5) M) caused a further displacement of the concentration-response curve (pIC50 values between 7.14 and 6.57) and decreased the maximum relaxant responses in all three cranial arteries (Imax values between 62% and 39%). 6. In conclusion, this is the first study which show mRNA encoding histamine H1- and H2-receptors in human cranial arteries. The results indicate that histamine-induced relaxation of human cranial arteries is partially mediated via an endothelial H1-receptor coupled to the production of nitric oxide and partially via a H2-receptor associated with the smooth muscle cells. In addition, there is evidence for a contractile H1-receptor in the smooth muscle cells in these arteries.
Similar articles
-
Histamine receptors on human isolated pulmonary arterial muscle preparations: effects of endothelial cell removal and nitric oxide inhibitors.J Pharmacol Exp Ther. 1992 Feb;260(2):762-7. J Pharmacol Exp Ther. 1992. PMID: 1531360
-
Histamine actions in dog retinal central arteries as compared to those in middle cerebral and temporal arteries.J Ocul Pharmacol Ther. 1995 Summer;11(2):167-76. doi: 10.1089/jop.1995.11.167. J Ocul Pharmacol Ther. 1995. PMID: 8564637
-
Histamine-induced modulation of vascular tone in the isolated chicken basilar artery: a possible involvement of endothelium.Comp Biochem Physiol C Toxicol Pharmacol. 2008 Apr;147(3):339-44. doi: 10.1016/j.cbpc.2007.12.002. Epub 2008 Jan 11. Comp Biochem Physiol C Toxicol Pharmacol. 2008. PMID: 18280220
-
Characterization and distribution of histamine H1- and H2-receptors in precapillary vessels.J Cardiovasc Pharmacol. 1984;6 Suppl 4:S587-97. doi: 10.1097/00005344-198406004-00005. J Cardiovasc Pharmacol. 1984. PMID: 6083401 Review.
-
[The H1 and H2 histamine receptors].Allerg Immunol (Paris). 1988 Nov;20(9):317-25. Allerg Immunol (Paris). 1988. PMID: 2905135 Review. French.
Cited by
-
Nitric oxide synthase inhibitors can antagonize neurogenic and calcitonin gene-related peptide induced dilation of dural meningeal vessels.Br J Pharmacol. 2002 Sep;137(1):62-8. doi: 10.1038/sj.bjp.0704842. Br J Pharmacol. 2002. PMID: 12183331 Free PMC article.
-
Possible role of histamine (H1- and H2-) receptors in the regulation of meningeal blood flow.Br J Pharmacol. 2002 Nov;137(6):874-80. doi: 10.1038/sj.bjp.0704946. Br J Pharmacol. 2002. PMID: 12411419 Free PMC article.
-
Histamine regulates cytokine production in maturing dendritic cells, resulting in altered T cell polarization.J Clin Invest. 2001 Dec;108(12):1865-73. doi: 10.1172/JCI13930. J Clin Invest. 2001. PMID: 11748270 Free PMC article.
-
BIBN4096BS is a potent competitive antagonist of the relaxant effects of alpha-CGRP on human temporal artery: comparison with CGRP(8-37).Br J Pharmacol. 2002 May;136(1):120-6. doi: 10.1038/sj.bjp.0704682. Br J Pharmacol. 2002. PMID: 11976276 Free PMC article.
-
Activation of hexosamine pathway impairs nitric oxide (NO)-dependent arteriolar dilations by increased protein O-GlcNAcylation.Vascul Pharmacol. 2012 Mar-Apr;56(3-4):115-21. doi: 10.1016/j.vph.2011.11.003. Epub 2011 Dec 3. Vascul Pharmacol. 2012. PMID: 22155161 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases